Gambaran Biokimia Hati Pada Anak Thalassemia Mayor di RSUP Haji Adam Malik Medan Tahun 2014
38
36
DAFTAR PUSTAKA
Aessopos, A., Farmakis D., Deftereos S., Tsironi M., Tassiopoulos S., Moyssakis
I., et al., 2005.Thalassemia heart disease: a comparative evaluation of
thalassemia major and thalassemia intermedia . Chest 2005, 127:1523-
1530.
Bacon, B.R., Brown K.E., 1996. Iron metabolism and disorders of iron overload.
Dalam: Kaplowirz N, penyunting. Biliary disease. Edisi II. Baltimore:
Williams & Wilkins. H. 349-62
Combes, B., and Schenker S., 1969. Laboratory test. Disease of the liver . J.B.
Lippincott
Co,
Philadelphia
Toronto.
Available
from:
http://www.ncbi.nlm.nih.gov/pubmed/12393486?dopt=Abstract
Dewi, S., 2009. Karakteristik penderita thalassemia yang rawat inap di rumah
sakit umum pusat H. adam malik medan tahun 2006-2008.
Dorland,2009.,Kamus Kedokteran Dorland. 28th ed. Jakarta: EGC, 1087.
Eleftheriou,
A.,
2007.
About
Thalassaemia.Published
by
Thalassaemia
International Federation, Cyprus.
Ganie, A., 2004. Kajian DNA Thalassemia alpha di Medan.USU Press, Medan.
Ganie, A., 2005. Thalassemia: Permasalahan dan Penanganannya. Universitas
Sumatera Utara, Medan Harsono. 2000. Kapita Selekta Neurologi . Gajah
Mada University Press, Yogyakarta.
Hoffbrand, A., dkk, 2005. Kapita Selekta Hematologi. Penerbit Buku Kedokteran
EGC, Jakarta.
Jelvehgari, M., and S.O Mashayekhi., 2007. Demographic and Clinical Aspects in
Thalassemic or Hemophilic Patients Reffered to Pediatric Hospital in
Tabriz
City,
2004,
Iran. Available
from:
http://www.researchgate.net/publication/26589949
Kaplan, M.M. 1993. Laboratory tests. Dalam: Schiff L, Schiff ER, penyunting.
Disease of the liver . Edisi ke-7. Philadelphia: JB Lippincott Company. H.
108-44
39
37
Kelly, DA.,Useful investigations in the assessment of liver disease . Dalam:
Diseases of the liver and biliary system in children. Oxford: Blackwell
Science Ltd, 1999. h. 3-8.
Kumar, P., Ghalaut V.S., Abrol, P., Sen J., dan Schdeva A., 2014. Effect of
Different Modalities of Chelation in Beta Thalassemia. Available from:
http://www.jcdr.net/back_issues.asp?issn=0973-709x&year=2010.
[Accessed 14 December 2015].
Laksmitawati, D.R., Handayani S., Udyaningsih-Freisleben S.K., Kurniati V.,
Adhiyanto C., Hidayat J., et al., 2013. Iron Status and Oxidate Stress in
Beta Thalassemia Patients in Jakarta.
Laksmitawati, D.R., Handayani S., Udyaningsih-Freisleben S.K., Kurniati V.,
Adhiyanto C., 3, Hidayat J., et al.,Iron Status and Oxidate Stress in Beta
Thalassemia Patients in Jakarta
Lawrence, M., 2003. Diagnosis dan Terapi Kedokteran Penyakit Dalam. Penerbit
Salemba Medika, Jakarta.
Lowry, F., 2008. Chelation May Reverse Thalassemia Complications. Internal
Medicine News 41.7 : 25.
Olivieri NF. The beta-thalassemias. N Engl J Med. 1999 Jul 8;341(2):99-109.
Review. Erratum in: N Engl J Med 1999 Oct 28;341(18):1407.
Rejeki, Sri., Pradani P., Nurhayati J., Supriyanto., 2014. Model prediksi
Kebutuhan Darah untuk Penderita Talasemia Mayor.
Soelaiman, B.H., 1976. Aplikasi Klinik dari Tes Faal Hati. Majalah Ilmu Penyakit
Dalam Vol. IX No. 1
Soliman, A., Mohamed Y., Fawzia A.Y., Lowla A., Noora A., Ami S., et al.,
2014. Longitudinal Study on Liver Functions in Patients with Thalassemia
Major before and after Deferasinox (DFX) Therapy. [Accessed 14
December 2015]
Suyono, S., 2001. Buku Ajar Ilmu Penyakit Dalam. Jilid II. Balai Penerbit FKUI,
Jakarta.
Tavill, AS., Hemochromatosis. Dalam Schiff L, Schiff ER, penyunting. Diseases
of the liver. Edisi ke-7. Philadel- phia: JB Lippincott Company, 1993. h.
40
38
669-691.
TIF., 2008. Guidelines for the Clinical Management of Thalassaemia . Available
from: http://www.thalassaemia.org.cy
Wahidiyat, I.,Penelitian thalassemia di Jalarta. Tesis, 1979.
Weatherall, D.J., Clegg, J.B., 2001. The Thalassemia Syndromes. Oxford:
Blackwell Science. 846p.
Whitby, L.G., Percy-Robb, I.W., and Smith, A.F. 1980. Lecture Notes on Clinical
Chemistry, 2ndEd. Blackwell Scientific Publications, Osney Mead,
Oxford.
Wilkins, I.,2009.Nonimmune hydrops. In Creasy and Resnick's Maternal FetalMedicine Principles and Practice sixth ed.Ed Creasy R et al., Saunders.
Pp505-517
Zilva, J.F.,
and Pannall, P.R. 1979. Clinical Chemistry in Diagnosis and
Treatment, 3rdEd. Lioyd-Luke (Medicine Books) Ltd. London.
36
DAFTAR PUSTAKA
Aessopos, A., Farmakis D., Deftereos S., Tsironi M., Tassiopoulos S., Moyssakis
I., et al., 2005.Thalassemia heart disease: a comparative evaluation of
thalassemia major and thalassemia intermedia . Chest 2005, 127:1523-
1530.
Bacon, B.R., Brown K.E., 1996. Iron metabolism and disorders of iron overload.
Dalam: Kaplowirz N, penyunting. Biliary disease. Edisi II. Baltimore:
Williams & Wilkins. H. 349-62
Combes, B., and Schenker S., 1969. Laboratory test. Disease of the liver . J.B.
Lippincott
Co,
Philadelphia
Toronto.
Available
from:
http://www.ncbi.nlm.nih.gov/pubmed/12393486?dopt=Abstract
Dewi, S., 2009. Karakteristik penderita thalassemia yang rawat inap di rumah
sakit umum pusat H. adam malik medan tahun 2006-2008.
Dorland,2009.,Kamus Kedokteran Dorland. 28th ed. Jakarta: EGC, 1087.
Eleftheriou,
A.,
2007.
About
Thalassaemia.Published
by
Thalassaemia
International Federation, Cyprus.
Ganie, A., 2004. Kajian DNA Thalassemia alpha di Medan.USU Press, Medan.
Ganie, A., 2005. Thalassemia: Permasalahan dan Penanganannya. Universitas
Sumatera Utara, Medan Harsono. 2000. Kapita Selekta Neurologi . Gajah
Mada University Press, Yogyakarta.
Hoffbrand, A., dkk, 2005. Kapita Selekta Hematologi. Penerbit Buku Kedokteran
EGC, Jakarta.
Jelvehgari, M., and S.O Mashayekhi., 2007. Demographic and Clinical Aspects in
Thalassemic or Hemophilic Patients Reffered to Pediatric Hospital in
Tabriz
City,
2004,
Iran. Available
from:
http://www.researchgate.net/publication/26589949
Kaplan, M.M. 1993. Laboratory tests. Dalam: Schiff L, Schiff ER, penyunting.
Disease of the liver . Edisi ke-7. Philadelphia: JB Lippincott Company. H.
108-44
39
37
Kelly, DA.,Useful investigations in the assessment of liver disease . Dalam:
Diseases of the liver and biliary system in children. Oxford: Blackwell
Science Ltd, 1999. h. 3-8.
Kumar, P., Ghalaut V.S., Abrol, P., Sen J., dan Schdeva A., 2014. Effect of
Different Modalities of Chelation in Beta Thalassemia. Available from:
http://www.jcdr.net/back_issues.asp?issn=0973-709x&year=2010.
[Accessed 14 December 2015].
Laksmitawati, D.R., Handayani S., Udyaningsih-Freisleben S.K., Kurniati V.,
Adhiyanto C., Hidayat J., et al., 2013. Iron Status and Oxidate Stress in
Beta Thalassemia Patients in Jakarta.
Laksmitawati, D.R., Handayani S., Udyaningsih-Freisleben S.K., Kurniati V.,
Adhiyanto C., 3, Hidayat J., et al.,Iron Status and Oxidate Stress in Beta
Thalassemia Patients in Jakarta
Lawrence, M., 2003. Diagnosis dan Terapi Kedokteran Penyakit Dalam. Penerbit
Salemba Medika, Jakarta.
Lowry, F., 2008. Chelation May Reverse Thalassemia Complications. Internal
Medicine News 41.7 : 25.
Olivieri NF. The beta-thalassemias. N Engl J Med. 1999 Jul 8;341(2):99-109.
Review. Erratum in: N Engl J Med 1999 Oct 28;341(18):1407.
Rejeki, Sri., Pradani P., Nurhayati J., Supriyanto., 2014. Model prediksi
Kebutuhan Darah untuk Penderita Talasemia Mayor.
Soelaiman, B.H., 1976. Aplikasi Klinik dari Tes Faal Hati. Majalah Ilmu Penyakit
Dalam Vol. IX No. 1
Soliman, A., Mohamed Y., Fawzia A.Y., Lowla A., Noora A., Ami S., et al.,
2014. Longitudinal Study on Liver Functions in Patients with Thalassemia
Major before and after Deferasinox (DFX) Therapy. [Accessed 14
December 2015]
Suyono, S., 2001. Buku Ajar Ilmu Penyakit Dalam. Jilid II. Balai Penerbit FKUI,
Jakarta.
Tavill, AS., Hemochromatosis. Dalam Schiff L, Schiff ER, penyunting. Diseases
of the liver. Edisi ke-7. Philadel- phia: JB Lippincott Company, 1993. h.
40
38
669-691.
TIF., 2008. Guidelines for the Clinical Management of Thalassaemia . Available
from: http://www.thalassaemia.org.cy
Wahidiyat, I.,Penelitian thalassemia di Jalarta. Tesis, 1979.
Weatherall, D.J., Clegg, J.B., 2001. The Thalassemia Syndromes. Oxford:
Blackwell Science. 846p.
Whitby, L.G., Percy-Robb, I.W., and Smith, A.F. 1980. Lecture Notes on Clinical
Chemistry, 2ndEd. Blackwell Scientific Publications, Osney Mead,
Oxford.
Wilkins, I.,2009.Nonimmune hydrops. In Creasy and Resnick's Maternal FetalMedicine Principles and Practice sixth ed.Ed Creasy R et al., Saunders.
Pp505-517
Zilva, J.F.,
and Pannall, P.R. 1979. Clinical Chemistry in Diagnosis and
Treatment, 3rdEd. Lioyd-Luke (Medicine Books) Ltd. London.